Phase I/II Study of Satraplatin Plus Radiotherapy
Phase 1
- Conditions
- Renal impairment patients with squamous cell carcinoma of the head and neck
- Registration Number
- JPRN-jRCT2080221482
- Lead Sponsor
- Yakult Honsha Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
(1) Histologically proven squamous cell carcinoma
(2) Primary lesion located at oropharynx, hypopharynx, or larynx
(3) Unresectable locally advanced head and neck cancer
(4) ECOG performance status (PS) :0-1
(5) Calculated creatinine clearance > 25 mL/min, < 60 mL/min
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method